Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Madeddu

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Circulation|June 27, 2001
Giorgio OlivettiP Madeddu
Pharmacological Research|September 1, 1993
Receptor antagonists of bradykinin: a new tool to study the cardiovascular effects of endogenous kininsP Madeddu
Current Pharmaceutical Design|September 17, 2011
The role of chemokines, cytokines and adhesion molecules in stem cell trafficking and homingY Cui, P Madeddu
Hypertension (Dallas, Tex. : 1979)|December 22, 1999
Can knockout mice help dissect relevant genes in hypertension? Evidence and confounding factorsP Madeddu, C Emanueli
Trends in Pharmacological Sciences|September 7, 2001
Targeting kinin receptors for the treatment of tissue ischaemiaC Emanueli, P Madeddu
Pharmacological Research|June 1, 1997
Effect of early blockade of bradykinin B2-receptors on the blood pressure phenotype of normotensive and spontaneously hypertensive ratsC Emanueli, P Madeddu
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 31, 2004
Angiogenesis therapy with human tissue kallikrein for the treatment of ischemic diseasesC Emanueli, P Madeddu
American Journal of Hypertension|November 24, 1999
Role of the kallikrein-kinin system in the maturation of cardiovascular phenotypeC Emanueli, P Madeddu
British Journal of Pharmacology|August 7, 2001
Angiogenesis gene therapy to rescue ischaemic tissues: achievements and future directionsC Emanueli, P Madeddu
Hypertension (Dallas, Tex. : 1979)|August 1, 1995
Does blockade of the renin-angiotensin system prevent heritability of genetic hypertension?P Madeddu, N Glorioso
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Circulation|June 27, 2001
Giorgio OlivettiP Madeddu
Pharmacological Research|September 1, 1993
Receptor antagonists of bradykinin: a new tool to study the cardiovascular effects of endogenous kininsP Madeddu
Current Pharmaceutical Design|September 17, 2011
The role of chemokines, cytokines and adhesion molecules in stem cell trafficking and homingY Cui, P Madeddu
Hypertension (Dallas, Tex. : 1979)|December 22, 1999
Can knockout mice help dissect relevant genes in hypertension? Evidence and confounding factorsP Madeddu, C Emanueli
Trends in Pharmacological Sciences|September 7, 2001
Targeting kinin receptors for the treatment of tissue ischaemiaC Emanueli, P Madeddu
Pharmacological Research|June 1, 1997
Effect of early blockade of bradykinin B2-receptors on the blood pressure phenotype of normotensive and spontaneously hypertensive ratsC Emanueli, P Madeddu
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 31, 2004
Angiogenesis therapy with human tissue kallikrein for the treatment of ischemic diseasesC Emanueli, P Madeddu
American Journal of Hypertension|November 24, 1999
Role of the kallikrein-kinin system in the maturation of cardiovascular phenotypeC Emanueli, P Madeddu
British Journal of Pharmacology|August 7, 2001
Angiogenesis gene therapy to rescue ischaemic tissues: achievements and future directionsC Emanueli, P Madeddu
Hypertension (Dallas, Tex. : 1979)|August 1, 1995
Does blockade of the renin-angiotensin system prevent heritability of genetic hypertension?P Madeddu, N Glorioso
Pageof 14